Rhox3 inhibitors are a class of chemical compounds specifically designed to target and modulate the activity of the Rhox3 protein, a member of the reproductive homeobox (Rhox) gene family. Rhox3 is a transcription factor that plays a significant role in the regulation of gene expression in reproductive tissues, particularly in the testes and ovaries. It is involved in critical processes such as spermatogenesis, oogenesis, and the development and function of reproductive organs. Rhox3 exerts its influence by binding to specific DNA sequences and regulating the transcription of target genes that are essential for reproductive cell development and maintenance. Inhibitors of Rhox3 are designed to interfere with its DNA-binding activity or disrupt its interaction with other components of the transcriptional machinery, thereby allowing researchers to study the specific roles of Rhox3 in reproductive biology and gene regulation.
The development of Rhox3 inhibitors involves a comprehensive approach that includes understanding the structure and function of the Rhox3 protein. Structural biology techniques such as X-ray crystallography, cryo-electron microscopy, and nuclear magnetic resonance (NMR) spectroscopy are employed to determine the three-dimensional configuration of Rhox3. This structural information is critical for identifying the DNA-binding domain and other functional regions of the protein that are essential for its role as a transcription factor. Computational tools like molecular docking and virtual screening are then used to identify small molecules that can specifically bind to these key regions, effectively inhibiting the activity of Rhox3. Once potential inhibitors are identified, they are synthesized and tested in vitro to assess their binding affinity, specificity, and inhibitory potency. Through iterative cycles of chemical optimization, these inhibitors are refined to improve their effectiveness and selectivity. The study of Rhox3 inhibitors not only provides insights into the specific functions of this transcription factor in reproductive processes but also contributes to a broader understanding of the mechanisms that regulate gene expression in reproductive tissues, highlighting the complex interplay between transcription factors and the genes they control.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, might influence signaling pathways intersecting with Rhox3's role in cell cycle and growth regulation. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
EGFR inhibitor, potentially alters pathways involved in cell proliferation, intersecting with Rhox3's cellular functions. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
SRC family kinase inhibitor, could modulate pathways Rhox3 is involved in, particularly in cell differentiation. | ||||||
ABT-199 | 1257044-40-8 | sc-472284 sc-472284A sc-472284B sc-472284C sc-472284D | 1 mg 5 mg 10 mg 100 mg 3 g | $118.00 $337.00 $520.00 $832.00 $1632.00 | 10 | |
BCL-2 inhibitor, may affect apoptotic pathways, potentially influencing Rhox3's role in cell survival. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor, might impact protein degradation pathways where Rhox3 plays a role. | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $420.00 | 32 | |
Dual EGFR and HER2 inhibitor, could modulate signaling pathways that Rhox3 might be involved in, especially in growth regulation. | ||||||
Everolimus | 159351-69-6 | sc-218452 sc-218452A | 5 mg 50 mg | $131.00 $651.00 | 7 | |
mTOR inhibitor, might affect signaling pathways relevant to Rhox3's function in cell proliferation and survival. | ||||||
Nilotinib | 641571-10-0 | sc-202245 sc-202245A | 10 mg 25 mg | $209.00 $413.00 | 9 | |
BCR-ABL inhibitor, potentially influences pathways associated with Rhox3's role in cellular processes. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
RAF kinase inhibitor, potentially impacts cell signaling pathways intersecting with Rhox3's function. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
CDK4/6 inhibitor, may impact cell cycle regulation pathways potentially connected to Rhox3's activity. | ||||||